Benjamin Oakes

Benjamin Oakes is a renowned figure at the intersection of molecular and genetic engineering, focused on revolutionizing the landscape of disease treatment.

He holds a Doctor of Philosophy (PhD) from the University of California, Berkeley, a Bachelor of Arts from Colby College, and also studied at The Pingry School.

Benjamin currently serves as the Chief Executive Officer at Scribe Therapeutics and has previously held positions such as Entrepreneurial Fellow at the Innovative Genomics Institute.

His academic and research background includes roles like PhD Candidate in Molecular & Cell Biology at UC Berkeley, Research Specialist at the Lewis-Sigler Institute for Integrative Genomics at Princeton University, and Independent Researcher at the Fekete Lab at Colby College.

Benjamin Oakes has also gained experience through various research internships at Pfizer, Rutgers University, and exposure to areas like neuroscience, toxicology, and flow cytometry.